Program

We are delighted to announce an exciting line up of renowned speakers from all over the world for Biopharma Trends 2018: Towards Industry 4.0. The conference program – a "work in progress" – can be viewed below:

Tuesday, November 13

Time Session Title
08:00 - 09:20 Registration and coffee
09:20 - 09:30 Welcome to Biopharma Trends: Towards Industry 4.0
Session 1: Understanding the Vision
09:30 - 10:10 Biopharma Factory of the Future
Frank Cordes , Boston Consulting Group
10:10 - 10:50 Transition to a new future
Jim Breen , J&J
10:50 - 11:20 Coffee Break
11:20 - 12:00 Biopharma 4.0 - Digital transformation of bioprocessing
Per Lidén , GE Healthcare Life Sciences
12:00 – 13:00 PANEL DISCUSSION with LIVE Q&A: “Industry 4.0: Hope or Hype?”
13:00 - 14:00 Networking lunch
Session 2: Riding the Big Data Wave
14:00 - 14:40 The application of advanced data analytics to enhance biopharmaceutical production
Colin Clarke , NIBRT
14:40 - 15:20 Data Analytics in Bio Manufacturing
Caitlin O'Mahony-Hartnett , Janssen Sciences Ireland
15:20 - 15:40 Tea Break
Session 3: Finding Inspiration from Adjacent Sectors
15:40 - 16:10 How Biopharma Compares with Other High Tech Sectors
Lucy Foley , Centre for Process Innovation
16:10 - 16:40 Drug Discovery's Digital Chemistry Future
Jonas Boström , AstraZeneca
16:40 - 17:10 Future of the Pharmaceutical Supply Chain
Eduard Viladesau , Boston Consulting Group
17:10 - 19:00 Networking Drinks Reception

Wednesday, November 14

Time Session Title
Session 4: Taking Practical Steps Towards Industry 4.0
09:00 - 09:40 How to get to Industry 4.0 from Industry (1.0)^n
Bernhardt L. Trout , Massachusetts Institute of Technology
09:40 - 10:20 Destination Biopharma 4.0 – a Journey with Hurdles
Gerald Kierans , Pfizer Pharmaceuticals
10:20 – 11:20 Networking Brunch
11:20 - 12:00 Industry 4.0: How to Swim with the Tide
Deirdre Carey , Eli Lilly and Company
12:40 - 13:20 The Future of Biopharmaceutical Manufacturing – What Should, Must and Will Change
Harold Baseman , ValSource LLC
13:20 - 14:20 PANEL DISCUSSION 2 with LIVE Q&A: “Learning to walk – and jump hurdles – before we run…”
14:20 - 14:30 Closing Remarks
14:30 - 16:00 Farewell Drinks

Industry 4.0 Overview

  • What exactly does Industry 4.0 mean in the context of the biopharmaceutical industry?
  • What are the challenges and potential benefits?

Big Data

  • In the next five years, pharma will become more globally connected. How can we leverage the speed and availability of data to drive faster decisions in pharma research, development and manufacturing?
  • How can we move from the cell to the facility by developing data mining approaches for biopharmaceutical manufacturing?

Enabling Technologies

  • Advanced process analytical technologies/smart sensors
  • Artificial intelligence and cloud-based technologies
  • Internet of Things (IoT)/intelligent automation
  • Virtual and augmented realities
  • Cyber-security

System Integration

  • How can the industry benefit from integration of functions, together with continued implementation of continuous manufacturing?
  • How can companies become quicker at adopting a digital approach to clinical research so that big and small technology players do not make them irrelevant?

Case Studies

  • Where and how has Industry 4.0 been successfully adopted so far in the pharma industry?
  • How are the early adopters finding the transition?
  • What next steps are being taken down the road to Industry 4.0

*presentation times subject to change